Phase 1 study of ONO-7056
Phase 1
- Conditions
- Solid tumor
- Registration Number
- JPRN-jRCT2080221709
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
1.20 years or older of age
2.Patients with solid tumor pathologically documented by tissue diagnosis or cytodiagnosis
3.Advanced/relapsed cancer patients with no standard or adequate therapeutic options
Exclusion Criteria
1.Patients with active infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety<br>Pharmacokinetics, Efficacy, Biomarkers
- Secondary Outcome Measures
Name Time Method